Here, the XPO7-NPAT axis was determined to be a key vulnerability in TP53 mutant AML following genome-wide CRISPR screen in isogenic Trp53-WT and Trp53-KO murine AML models [219]. This evidence concerns the gene TP53 and acute myeloid leukemia.